Viewing Study NCT03927261

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 12:17 PM

Ignite Modification Date: 2026-01-05 @ 3:04 AM

Study NCT ID: NCT03927261

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2024-11-08

First Post: 2019-04-23

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS

Sponsor: Precigen, Inc

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module